These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35055183)

  • 1. Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson's Disease.
    Lee S; Hong DG; Yang S; Kim J; Baek M; Kim S; Thirumalai D; Chung HY; Chang SC; Lee J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
    Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades.
    Wang MJ; Huang HY; Chen WF; Chang HF; Kuo JS
    J Neuroinflammation; 2010 Dec; 7():99. PubMed ID: 21194439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Deleidi M; Serapide MF; Pluchino S; Marchetti B
    J Neurosci; 2012 Feb; 32(6):2062-85. PubMed ID: 22323720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirubin-3'-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.
    Sathiya Priya C; Vidhya R; Kalpana K; Anuradha CV
    Int Immunopharmacol; 2019 May; 70():396-407. PubMed ID: 30856390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons.
    Petit-Paitel A; Brau F; Cazareth J; Chabry J
    PLoS One; 2009; 4(5):e5491. PubMed ID: 19430525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
    Song SY; Kim IS; Koppula S; Park JY; Kim BW; Yoon SH; Choi DK
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
    Hedya SA; Safar MM; Bahgat AK
    Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
    Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
    Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3
    Zhu J; Xu X; Liang Y; Zhu R
    Biomed Res Int; 2021; 2021():8814862. PubMed ID: 33506036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
    Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic.
    Hong S; Ju S; Yoo JW; Ha NC; Jung Y
    Biomater Sci; 2021 Sep; 9(19):6584-6596. PubMed ID: 34582526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
    Duka T; Duka V; Joyce JN; Sidhu A
    FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
    Li DW; Liu ZQ; Chen W; Yao M; Li GR
    Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
    Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
    J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Neuroinflammatory Effects of a Semi-Synthetic Isoorientin-Based Glycogen Synthase Kinase-3β Inhibitor in Lipopolysaccharide-Activated Microglial Cells.
    Xu M; Lantz MJ; Nichols RA; Li QX
    ACS Chem Neurosci; 2022 Jan; 13(1):43-52. PubMed ID: 34913695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling.
    Singh S; Mishra A; Bharti S; Tiwari V; Singh J; Parul ; Shukla S
    Mol Neurobiol; 2018 Aug; 55(8):6500-6517. PubMed ID: 29327199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.